Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hyperonkotické koloidy a akutní poškození ledvin u kriticky nemocných
[Risk associated with hyperoncotic colloids in patients with shock]

Frederique Schortgen, Emmanuelle Girou, Nicolas Deye, Laurent Brochard, CRYCO Study Group

. 2009 ; 7 (1) : 9-10.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07526132

Crystalloids, artificial and natural colloids have been opposed as representing different strategies for shock resuscitation, but it may be relevant to distinguish fluids based on their oncotic characteristics. This study assessed the risk of renal adverse events in patients with shock resuscitated using hypo-oncotic colloids, artificial hyperoncotic colloids, hyperoncotic albumin or crystalloids, according to physician's choice. PARTICIPANTS AND SETTING: International prospective cohort study including 1,013 ICU patients needing fluid resuscitation for shock. Patients suffering from cirrhosis or receiving plasma were excluded. MEASUREMENTS AND RESULTS: Influence of different types of colloids and crystalloids on the occurrence of renal events (twofold increase in creatinine or need for dialysis) and mortality was assessed using multivariate analyses and propensity score. Statistical adjustment was based on severity at the time of resuscitation, risks factor for renal failure, and on variables influencing physicians' preferences regarding fluids. A renal event occurred in 17% of patients. After adjustment on potential confounding factors and on propensity score for the use of hyperoncotic colloids, the use of artificial hyperoncotic colloids [OR: 2.48 (1.24-4.97)] and hyperoncotic albumin [OR: 5.99 (2.75-13.08)] was significantly associated with occurrence of renal event. Overall ICU mortality was 27.1%. The use of hyperoncotic albumin was associated with an increased risk of ICU death [OR: 2.79 (1.42-5.47)]. CONCLUSIONS: This study suggests that harmful effects on renal function and outcome of hyperoncotic colloids may exist. Although an improper usage of these compounds and confounding factors cannot be ruled out, their use should be regarded with caution, especially because suitable alternatives exist

Risk associated with hyperoncotic colloids in patients with shock

Recenze v:

Komentář [k článku Hyperonkotické koloidy a akutní poškození ledvin u kriticky nemocných].

000      
00000naa 2200000 a 4500
001      
bmc07526132
003      
CZ-PrNML
005      
20111210142914.0
008      
090709s2009 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Schortgen, Frederique
245    10
$a Hyperonkotické koloidy a akutní poškození ledvin u kriticky nemocných / $c Frederique Schortgen, Emmanuelle Girou, Nicolas Deye, Laurent Brochard, CRYCO Study Group
246    11
$a Risk associated with hyperoncotic colloids in patients with shock
314    __
$a Réanimation Médicale, AP-HP, Groupe Hospitalier Albert Chenevier, Créteil frederique.schortgen@hmn.aphp.fr
520    9_
$a Crystalloids, artificial and natural colloids have been opposed as representing different strategies for shock resuscitation, but it may be relevant to distinguish fluids based on their oncotic characteristics. This study assessed the risk of renal adverse events in patients with shock resuscitated using hypo-oncotic colloids, artificial hyperoncotic colloids, hyperoncotic albumin or crystalloids, according to physician's choice. PARTICIPANTS AND SETTING: International prospective cohort study including 1,013 ICU patients needing fluid resuscitation for shock. Patients suffering from cirrhosis or receiving plasma were excluded. MEASUREMENTS AND RESULTS: Influence of different types of colloids and crystalloids on the occurrence of renal events (twofold increase in creatinine or need for dialysis) and mortality was assessed using multivariate analyses and propensity score. Statistical adjustment was based on severity at the time of resuscitation, risks factor for renal failure, and on variables influencing physicians' preferences regarding fluids. A renal event occurred in 17% of patients. After adjustment on potential confounding factors and on propensity score for the use of hyperoncotic colloids, the use of artificial hyperoncotic colloids [OR: 2.48 (1.24-4.97)] and hyperoncotic albumin [OR: 5.99 (2.75-13.08)] was significantly associated with occurrence of renal event. Overall ICU mortality was 27.1%. The use of hyperoncotic albumin was associated with an increased risk of ICU death [OR: 2.79 (1.42-5.47)]. CONCLUSIONS: This study suggests that harmful effects on renal function and outcome of hyperoncotic colloids may exist. Although an improper usage of these compounds and confounding factors cannot be ruled out, their use should be regarded with caution, especially because suitable alternatives exist
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a albuminy $x škodlivé účinky $7 D000418
650    _2
$a koloidy $x škodlivé účinky $7 D003102
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a jednotky intenzivní péče $7 D007362
650    _2
$a isotonické roztoky $x škodlivé účinky $7 D007552
650    _2
$a nemoci ledvin $x chemicky indukované $x mortalita $7 D007674
650    _2
$a lidé středního věku $7 D008875
650    _2
$a odds ratio $7 D016017
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rehydratační roztoky $x škodlivé účinky $7 D015532
650    _2
$a riziko $7 D012306
650    _2
$a šok $x terapie $7 D012769
651    _2
$a Evropa $x epidemiologie $7 D005060
700    1_
$a Girou, Emmanuelle
700    1_
$a Deye, Nicolas
700    1_
$a Brochard, Laurent
773    0_
$w MED00012709 $t Postgraduální nefrologie $g Roč. 7, č. 1 (2009), s. 9-10 $x 1214-178X
787    18
$w bmc07526134 $i Recenze v: $t Komentář [k článku Hyperonkotické koloidy a akutní poškození ledvin u kriticky nemocných]
856    41
$u http://www.transplant.cz/vzdelavani/2009/09_01_06.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2318 $c 893 $y 9
990    __
$a 20090709140420 $b ABA008
991    __
$a 20090907120522 $b ABA008
999    __
$a ok $b bmc $g 668430 $s 525685
BAS    __
$a 3
BMC    __
$a 2009 $b 7 $c 1 $d 9-10 $i 1214-178X $m Postgraduální nefrologie $x MED00012709
LZP    __
$a 2009-22/mkme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace